Trial Profile
A study evaluating pharmacokinetic drug–drug interactions among rosuvastatin, telmisartan, and amlodipine in a healthy Korean male population.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2017
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia
- Focus Pharmacokinetics
- 30 Oct 2017 New trial record